C. Lavigne

发表

Functionalised silica nanoparticles stable in serum-containing medium efficiently deliver siRNA targeting HIV-1 co-receptor CXCR4 in mammalian cells

A. Kell, M. Barnes, Kathryn Slater, 2012 .

Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides.

B. Lebleu, C. Lavigne, A. Thierry, 2004, Methods in enzymology.

Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range.

B. Lebleu, C. Lavigne, S. Resina, 2007, Biochimie.

Expression of the 5-HT2A serotoninergic receptor in human placenta and choriocarcinoma cells: mitogenic implications of serotonin.

C. Lavigne, R. Ouellette, C. Vaillancourt, 2005, Placenta.

The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin.

C. Lavigne, R. Ouellette, C. Vaillancourt, 2006, Biochemical and biophysical research communications.

Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells.

C. Lavigne, A. Thierry, 2007, Biochimie.

Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells

T. Ball, C. Lavigne, A. Meyers, 2013, BioResearch open access.

Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication

C. Lavigne, A. Thierry, J. Yelle, 2001, AAPS PharmSci.

Cell cycle arrest and apoptosis responses of human breast epithelial cells to the synthetic organosulfur compound p-methoxyphenyl p-toluenesulfonate.

C. Lavigne, R. Langler, Louis Cyr, 2008, Anticancer research.

Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?

C. Lavigne, A. Thierry, J. Yelle, 2008, AAPS PharmSci.

Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system.

C. Lavigne, A. Thierry, 1997, Biochemical and biophysical research communications.

Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages

A. Kell, M. Barnes, C. Lavigne, 2015, International journal of nanomedicine.

A rapid microwell fluorescence immunoassay for cellular protein detection

C. Lavigne, A. Thierry, Arméle Guignée, 2008, Biological Procedures Online.

Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor

A. Kell, M. Barnes, Kathryn Slater, 2013, Expert opinion on biological therapy.

Antiproliferative effects of a series of novel synthetic sulfonate esters on human breast cancer cell line MCF-7.

I. Crandall, C. Lavigne, R. Langler, 2007, Anticancer research.

Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophages

R. Vincent, C. Lavigne, A. Thierry, 2017, Nanobiomedicine.

Cryotreatment as a simple method for cell preparation in autologous tumor cell-based vaccination.

C. Lavigne, A. Thierry, S. Walshaw, 2010, International journal of oncology.

Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay

C. Lavigne, P. Sandstrom, F. Cholette, 2018, Archives of Virology.

Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay

Paul Sandstrom, Xuefen Yang, C. Lavigne, 2018, Archives of Virology.